South Africa: Medicine availability must be measured at pharmacy window

An opinion piece argues that South Africa's medicine stock-out monitoring should focus on patient-level availability at the pharmacy counter, not just central stock figures. The claim is an advocacy position, not a factual development, and its market impact is negligible.